4Cipriani A, Review: selective serotonin reuptake inhibitors as effective as tricyelic antidepressants for major depression, and may have fewer adverse effects[J]. Evid Based Ment Health, 2003, 6(4) :117.
5Zhang Y, Becker T, Ma Y, et al. A systematic review of Chinese randomized clinical trials of SSRI treatment of de- pression[J]. BMC Psychiatry, 2014, 14(1) :245.
6Ruhe HG, Huyser J, Swinkels JA, et al. Switching antide- pressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review[J]. J Clin Psychiatry, 2006, 67(12):1836-1855.
7Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement- based care in STAR * D: implications for clinical practice[J]. Am J Psychiatry, 2006, 163(1) .28-40.
8Trivedi MH, Hollander E, Nutt D, et al. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression[J]. J Clin Psychiatry, 2008, 69(2) : 246-258.
9Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion- SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression[J]. N Engl J Med, 2006,354 (12) : 1231-1242.
10Richardson-Jones JW, Craige CP, Guiard BP, et al. 5-HTIA autoreceptor levels determine vulnerability to stress and re- sponse to antidepressants[J]. Neuron, 2010,65(1) :40-52.
